Drug
Andrographis Paniculata
Andrographis Paniculata is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (50.0%)
N/A2 (50.0%)
Trials by Status
not_yet_recruiting125%
unknown125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Pressure of Obese Patients
NCT06520527
completedphase_3
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
NCT04196075
unknownphase_3
Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19
NCT05019326
completednot_applicable
Assessment of the Efficacy of Andrographis Paniculata in Subjects With Mild to Moderate Osteoarthritis
NCT03262792
Clinical Trials (4)
Showing 4 of 4 trials
NCT06520527Not Applicable
Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Pressure of Obese Patients
NCT04196075Phase 3
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
NCT05019326Phase 3
Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19
NCT03262792Not Applicable
Assessment of the Efficacy of Andrographis Paniculata in Subjects With Mild to Moderate Osteoarthritis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4